Suzanne E. Schindler
@suzanneeschindler.bsky.social
Clinical neurologist and neuroscientist dedicated to improving the diagnosis and treatment of dementia.
We have been trying to learn everything we can from our experiences with amyloid-targeting treatments to improve patient care. We present the findings from our first 234 patients treated with lecanemab in JAMA Neurology: ja.ma/42TLKzx
#ENDALZ
@WashUNeurology
#ENDALZ
@WashUNeurology
May 12, 2025 at 4:57 PM
We have been trying to learn everything we can from our experiences with amyloid-targeting treatments to improve patient care. We present the findings from our first 234 patients treated with lecanemab in JAMA Neurology: ja.ma/42TLKzx
#ENDALZ
@WashUNeurology
#ENDALZ
@WashUNeurology